Firefly Neuroscience (AIFF) Other financing activities (2020 - 2026)

Firefly Neuroscience has reported Other financing activities for 7 years, with the latest figure at $150000.0 in Q1 2026.

• On a quarterly basis, Other financing activities fell 98.3% year-over-year to $150000.0 in Q1 2026; TTM through Jun 2026 was $410000.0, a 95.37% decrease from a year earlier, with the FY2025 full-year figure at $9.1 million, up 25144.44% from the prior year.
• Other financing activities was $150000.0 for Q1 2026 at Firefly Neuroscience, down from $250000.0 in the prior quarter.
• The five-year high for Other financing activities was $8.8 million in Q1 2025, with the low at -$7400.0 in Q3 2023.
• Average Other financing activities over 5 years is $930764.2, with a median of $18399.5 recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Other financing activities surged 654.9% in 2022, then sank 401.92% in 2023.
• Over 5 years, Other financing activities stood at $2451.0 in 2022, then tumbled by 401.92% to -$7400.0 in 2023, then jumped by 532.43% to $32000.0 in 2024, then surged by 681.25% to $250000.0 in 2025, then sank by 40.0% to $150000.0 in 2026.
• The last three Other financing activities figures came in at $150000.0 (Q1 2026), $250000.0 (Q4 2025), and $10000.0 (Q3 2025), per Business Quant data.